DESADENOSINE Trademark

Trademark Overview


On Wednesday, August 16, 2000, a trademark application was filed for DESADENOSINE with the United States Patent and Trademark Office. The USPTO has given the DESADENOSINE trademark a serial number of 76113583. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Saturday, August 15, 2009. This trademark is owned by EPIGENESIS Pharmaceuticals, Inc.. The DESADENOSINE trademark is filed in the Pharmaceutical Products category with the following description:

Describing and providing medical diagnostic and pharmaceutical preparations with nucleotide sequences that have a low content of, or fully lack, adenosine, for testing, preventing, and therapeutically treating human and non-human animal respiratory ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms; pharmaceutical preparations for the treatment of airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory D...
desadenosine

General Information


Serial Number76113583
Word MarkDESADENOSINE
Filing DateWednesday, August 16, 2000
Status710 - CANCELLED - SECTION 8
Status DateSaturday, August 15, 2009
Registration Number2670996
Registration DateTuesday, January 7, 2003
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 15, 2002

Trademark Statements


Goods and ServicesDescribing and providing medical diagnostic and pharmaceutical preparations with nucleotide sequences that have a low content of, or fully lack, adenosine, for testing, preventing, and therapeutically treating human and non-human animal respiratory ailments that may be associated with hyper-sensitivity or hyper-responsiveness to adenosine, including bronchoconstriction, difficult breathing, impeded and obstructed lung airways, allergy(ies) and/or inflammation, which in many cases are adenosine receptor associated symptoms; pharmaceutical preparations for the treatment of airway and pulmonary diseases and conditions, such as asthma, pulmonary vasoconstriction, inflammation, allergies, asthma, impeded respiration, Acute Respiratory Distress Syndrome (ARDS), renal damage and failure, ischemia, resulting from the administration of certain drugs, including adenosine and other drugs for, for example, treating SupraVentricular Tachycardia (SVT), adenosine stress tests, infantile Respiratory Distress Syndrome (infantile RDS), pain, cystic fibrosis, allergic rhinitis, allergic bronchitis, pulmonary hypertension, pulmonary vascoconstriction, emphysema, chronic obstructive pulmonary disease (COPD), as well as cancers including leukemias, lymphomas, carcinomas, and the like, e.g., colon cancer, breast cancer, lung cancer, pancreatic cancer, hepatocellular carcinoma, kidney cancer, melanoma, hepatic metastases, etc., as well as all other metastatic cancers, e.g., cancers which metastasized to the lung(s), breast, liver and prostate

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateSaturday, August 15, 2009
Primary Code005
First Use Anywhere DateThursday, August 31, 1995
First Use In Commerce DateThursday, November 30, 1995

Trademark Owner History


Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Party NameEPIGENESIS Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCranbury, NJ 08512

Trademark Events


Event DateEvent Description
Saturday, August 15, 2009CANCELLED SEC. 8 (6-YR)
Thursday, January 17, 2008CASE FILE IN TICRS
Tuesday, January 7, 2003REGISTERED-PRINCIPAL REGISTER
Tuesday, October 15, 2002PUBLISHED FOR OPPOSITION
Wednesday, September 25, 2002NOTICE OF PUBLICATION
Tuesday, March 5, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 27, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 22, 2001NON-FINAL ACTION MAILED
Wednesday, March 14, 2001ASSIGNED TO EXAMINER
Friday, February 16, 2001ASSIGNED TO EXAMINER